Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Icu Medical (ICUI) Revenue (2016 - 2025)

Icu Medical's Revenue history spans 17 years, with the latest figure at $540.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 14.15% year-over-year to $540.7 million, compared with a TTM value of $2.2 billion through Dec 2025, down 6.33%, and an annual FY2025 reading of $2.2 billion, down 6.33% over the prior year.
  • Revenue for Q4 2025 was $540.7 million at Icu Medical, up from $537.0 million in the prior quarter.
  • The five-year high for Revenue was $629.8 million in Q4 2024, with the low at $318.0 million in Q1 2021.
  • Average Revenue over 5 years is $523.4 million, with a median of $557.2 million recorded in 2022.
  • Year-over-year, Revenue soared 77.9% in 2022 and then dropped 14.15% in 2025.
  • Tracing ICUI's Revenue over 5 years: stood at $340.5 million in 2021, then skyrocketed by 69.74% to $578.0 million in 2022, then grew by 1.7% to $587.9 million in 2023, then grew by 7.14% to $629.8 million in 2024, then dropped by 14.15% to $540.7 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Revenue are $540.7 million (Q4 2025), $537.0 million (Q3 2025), and $548.9 million (Q2 2025).